Scientists have uncovered a surprising role for a small human protein once known only as a cancer marker, revealing that it acts as a rapid response system that switches on the moment skin is injured :contentReference[oaicite:0]{index=0}. The finding matters now because chronic wounds are rising worldwide, and current treatments often fail to restart stalled healing.
Fast Facts
Study: New research published in PNAS
Discovery: SerpinB3 acts as an early skin injury response signal
Why It Matters: Helps explain faster wound healing and links to cancer behavior
Key Evidence: Protein spikes at injury sites and accelerates repair in mice and human cells
Impact: May guide new treatments for chronic wounds and aggressive cancers
The team found that SerpinB3, long used as a clinical cancer biomarker, is actually a central part of the body’s natural wound repair system. The protein surges at injury sites, activates the cells that rebuild the skin surface, and then fades once the skin closes. This discovery introduces a new biological explanation for why the same molecule appears both in healing wounds and in dangerous cancers.
Researchers proved this by testing the protein in cultured human skin cells and in mouse models. They used genetic tools to track where SerpinB3 appears during healing and relied on advanced laboratory imaging to watch how cells behaved when exposed to the protein. These tests showed that injured skin cells quickly produced SerpinB3, shifted into a more mobile state, and migrated to close the wound faster.
This finding matters because chronic wounds affect millions of people and often resist treatment. A protein that naturally boosts skin repair could guide new therapies for burns, diabetic ulcers, and surgical recovery. The study also suggests that cancer cells may hijack this wound healing program, using SerpinB3 to move, invade, and resist treatment.
Experts say this discovery reframes how scientists view the protein. One of the lead authors noted that SerpinB3 behaves like an internal alarm that tells skin cells to switch from a resting state to a repair mode. Other scientists point out that this dual identity matches a long standing idea that tumors behave like wounds that do not heal.
This research connects skin biology to wider issues in public health, cancer treatment, and biotechnology. Understanding how SerpinB3 controls cell movement may improve skin graft recovery, advance regenerative medicine, and help researchers design cancer drugs that block the hijacked version of this repair program.
What happens next depends on learning exactly how SerpinB3 communicates with other healing pathways like TGF beta and EGF, which guide tissue repair. Scientists also want to know why the protein stays elevated after a wound closes and whether this lingering activity affects long term skin health.
The takeaway is clear. SerpinB3 is not just a cancer marker. It is a powerful part of the body’s natural repair system, and understanding it may lead to better treatments for wounds and new strategies against aggressive cancers.
Story Source:
Materials provided by Arizona State University. Content may be edited for style and length.
Journal Reference:
Jordan R. Yaron, Shubham Pallod, Sepideh Nezhadi, Holly M. Gildar, Jayda Hylton Pelaia, Jordan Roberts, Jacquelyn Kilbourne, Kaushal Rege. Squamous cell carcinoma antigen 1 SerpinB3 is an endogenous skin injury response element. PNAS, 2025. 122(43). DOI: 10.1073/pnas.2415164122